UnitedHealth Group Incorporated $UNH Shares Acquired by Banco Bilbao Vizcaya Argentaria S.A.

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Banco Bilbao Vizcaya Argentaria S.A. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 18.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,606 shares of the healthcare conglomerate's stock after buying an additional 9,774 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in UnitedHealth Group were worth $33,331,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Van Lanschot Kempen Investment Management N.V. increased its stake in UnitedHealth Group by 54.8% in the 1st quarter. Van Lanschot Kempen Investment Management N.V. now owns 73,672 shares of the healthcare conglomerate's stock valued at $38,586,000 after purchasing an additional 26,066 shares in the last quarter. JT Stratford LLC increased its stake in UnitedHealth Group by 47.9% in the 1st quarter. JT Stratford LLC now owns 3,564 shares of the healthcare conglomerate's stock valued at $1,867,000 after purchasing an additional 1,154 shares in the last quarter. Legacy Financial Advisors Inc. increased its stake in UnitedHealth Group by 1.4% in the 1st quarter. Legacy Financial Advisors Inc. now owns 5,676 shares of the healthcare conglomerate's stock valued at $2,973,000 after purchasing an additional 79 shares in the last quarter. Texas Capital Bank Wealth Management Services Inc increased its stake in UnitedHealth Group by 4.4% in the 1st quarter. Texas Capital Bank Wealth Management Services Inc now owns 17,100 shares of the healthcare conglomerate's stock valued at $8,956,000 after purchasing an additional 720 shares in the last quarter. Finally, Bank OZK increased its stake in UnitedHealth Group by 4.6% in the 1st quarter. Bank OZK now owns 766 shares of the healthcare conglomerate's stock valued at $401,000 after purchasing an additional 34 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the subject of several research analyst reports. Morgan Stanley dropped their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. KeyCorp lowered their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Finally, Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, UnitedHealth Group presently has an average rating of "Hold" and an average target price of $367.71.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Up 1.6%

Shares of NYSE UNH opened at $308.84 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a market cap of $279.71 billion, a price-to-earnings ratio of 13.38, a PEG ratio of 1.96 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock's 50-day simple moving average is $289.03 and its 200-day simple moving average is $394.17.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.80 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.